Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 44:105-108, doi:10.1016/j.jacc.2004.03.057
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeltser, D.
Right arrow Articles by Viskin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeltser, D.
Right arrow Articles by Viskin, S.

Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug

David Zeltser, MD*, Dan Justo, MD*, Amir Halkin, MD{dagger}, Raphael Rosso, MD{dagger}, Maya Ish-Shalom, MD{dagger}, Mordechai Hochenberg, MD{dagger} and Sami Viskin, MD{dagger},*

* Internal Medicine D, Tel Aviv–Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
{dagger} Cardiology, Tel Aviv–Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel



View larger version (29K):

[in a new window]
 
Figure 1 Flow chart describing the course of 163 consecutive patients with atrioventricular (AV) block not related to acute myocardial infarction, vasovagal syncope, digitalis toxicity, or radiofrequency ablation. The number of patients in each step appears in parentheses.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement